secwatch.observer — SEC 8-K summary
======================================

Issuer:     SilverBox Corp IV (SBXD)
CIK:        0002015947
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001104659-25-061082
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Parataxis definitively acquires control of Bridge Bio for KRW 25B to create Bitcoin treasury company
--------------------------------------------------------------------------------

- Parataxis Holdings to invest KRW 25 billion for controlling interest in Bridge Biotherapeutics (KOSDAQ: 288330).
- Post-closing, company renamed 'Parataxis Korea' and remains KOSDAQ-listed; will build Bitcoin treasury on Strategy/Metaplanet model.
- Edward Chin to join board; Andrew Kim to become CEO of renamed company; James Lee to lead biotech division.
- Transaction subject to shareholder approval; meeting expected in August 2025.
- Parataxis also closing another fund with same strategy and launching additional vehicles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2015947/000110465925061082/0001104659-25-061082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2015947/000110465925061082/tm2518539d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer